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Ocular gene therapy approaches have been developed for a variety of different diseases. 
In particular, clinical gene therapy trials for RPE65 mutations, X-linked retinoschisis, and 
choroideremia have been conducted at different centers in recent years, showing that 
adeno-associated virus (AAV)-mediated gene therapy is safe, but limitations exist as 
to the therapeutic benefit and long-term duration of the treatment. The technique of 
vector delivery to retinal cells relies on subretinal injection of the vector solution, causing 
a transient retinal detachment. Although retinal detachments are known to cause 
remodeling of retinal neuronal structures as well as significant cell loss, the possible 
effects of this short-term therapeutic retinal detachment on retinal structure and circuitry 
have not yet been studied in detail. In this study, retinal morphology and apoptotic 
status were examined in healthy rat retinas following AAV-mediated gene transfer via 
subretinal injection with AAV2/5.CMV.d2GFP or sham injection with fluorescein. Outer 
plexiform layer (OPL) morphology was assessed by immunohistochemical labeling, 
laser scanning confocal microscopy, and electron microscopy. The number of synaptic 
contacts in the OPL was quantified after labeling with structural markers. To assess 
the apoptotic status, inflammatory and pro-apoptotic markers were tested and TUNEL 
assay for the detection of apoptotic nuclei was performed. Pre- and postsynaptic 
structures in the OPL, such as synaptic ribbons or horizontal and bipolar cell processes, 
did not differ in size or shape in injected versus non-injected areas and control retinas. 
Absolute numbers of synaptic ribbons were not altered. No signs of relevant gliosis 
were detected. TUNEL labeling of retinal cells did not vary between injected and non-
injected areas, and apoptosis-inducing factor was not delocalized to the nucleus in 
transduced areas. The neuronal circuits in the OPL of healthy rat retinas undergoing 
AAV-mediated gene transfer were not altered by the temporary retinal detachment 
caused by subretinal injection, the presence of viral particles, or the expression of green 
fluorescent protein as a transgene. This observation likely requires further investigations 
in the dog model for RPE65 deficiency in order to determine the impact of RPE65 
transgene expression on diseased retinas in animals and men.
Keywords: rPe65, gene therapy, retinal degeneration, leber congenital amaurosis, retinal detachment, synaptic 
plasticity
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inTrODUcTiOn
Adeno-associated virus (AAV)-mediated gene therapy has facili-
tated tremendous progress in the therapy of hereditary retinal 
dystrophies in the last decade. A characteristic feature of retinal 
dystrophies is the progressive degeneration of photoreceptors 
in the retina leading to severely reduced vision to the point of 
blindness often early in life (1, 2). A growing number of genetic 
mutations have been identified over the past decades that can 
cause retinal dystrophy (3), among which mutations in the gene 
encoding the retinal pigment epithelial protein of 65 kDa (RPE65) 
are best characterized (4). This isomerase plays a crucial role in 
the visual cycle restoring the light sensitive chromophore 11-cis 
retinal from all-trans retinal (5, 6). Mutations in the RPE65 gene 
are associated with Leber’s congenital amaurosis type 2 or early 
onset severe retinal dystrophy, depending on the age of onset 
of severe visual impairment, which may vary widely in affected 
individuals (2, 7).
Several animal models have been described to model the 
pathological findings of RPE65 deficiency in human patients, 
most importantly the naturally occurring canine model of RPE65 
deficiency, the Swedish Briard dog (8). All of these animal models 
have been successfully used to implement new therapeutic strate-
gies, showing that AAV-mediated gene therapy is able to restore 
significant vision in affected animals (9–13).
First results from clinical trials were published in 2008, show-
ing that AAV-mediated gene transfer was safe and efficacious in 
human patients (14–17). Functional improvement was restricted 
most often to improved light sensitivity and occasionally to visual 
acuity, but there was no rescue of ERG recordings in treated 
individuals. Some patients developed extrafoveal fixation points, 
thereby suggesting preserved plasticity in retinal circuitry (18). 
Successive clinical trials and long-term follow-up have confirmed 
the safety of the treatment.
Why the efficacy results of the clinical trials fell short of the 
promising results of the murine and canine studies remains 
unclear. Different explanations have been discussed. One 
important point is that the genetic situation in humans is far 
more complex and heterogeneous than in the genetically homo-
geneous mouse lines or pure-bred dogs, thereby resulting in a 
greater variety in clinical symptoms and disease progression. The 
expression of non-functional proteins in patients with missense 
mutations could cause interferences with the therapeutic gene 
(19). Furthermore, the level of transgene expression seems to be 
crucial and may not be as high as necessary to restore enzyme 
function (20). Possible repercussions of these findings on retinal 
function have yet to be examined. Ultimately, subretinal injection 
and gene transfer as well as transgene expression could all affect 
retinal structures. Changes in retinal circuitry and cell function 
as well as gliosis and apoptosis might impair signaling pathways 
within the retina.
It has been shown that the synaptic circuitry within the retina 
retains a certain degree of plasticity and is perceptive to dynamic 
changes. In non-human primates, it has been demonstrated that 
change from dichromatic to trichromatic vision was possible 
following gene transfer of the missing chromophore (21, 22). 
The formation of ectopic synapses (synaptic sprouting) has been 
shown in animal models of different retinal degenerative diseases 
(23–26) as well as in genetically engineered mouse lines with 
missing rod or cone output (27, 28) and is typically considered to 
be a marker of ongoing neurodegeneration.
Experimental retinal detachments have also been shown to 
cause changes in the synaptic architecture of the outer plexiform 
layer (OPL), expression of photoreceptor-specific proteins and 
inner and outer segment structure (29–31). Thus, the transient 
retinal detachment caused by subretinal injections for gene 
delivery may also cause changes to retinal circuitry. Such effects 
have, however, not been further examined, owed perhaps to the 
circumstance that no severe adverse events in the preclinical gene 
therapy studies were observed. However, the results from the 
clinical studies revealed a complex image of reaction, both on the 
morphological and the functional levels suggesting that further 
understanding of the effects of therapeutic retinal detachment is 
important. The aim of our study was to examine the effects of 
subretinal AAV delivery on OPL structures and retinal circuitry 
in healthy retinas.
MaTerials anD MeThODs
animals, Vector Preparation, subretinal 
injection, and Tissue Preparation
All animals were cared for in accordance to the ARVO state-
ment for the use of animals in ophthalmic and vision research 
and EU directive 2010/63/EU. The protocol was approved by the 
Institutional Animal Care and Use Committee of the University 
of Nantes.
A total of 12 healthy Sprague-Dawley rats were used in this 
study. Subretinal injection was performed as previously described 
(32). Briefly, a transscleral/transchoroidal approach was used by 
first puncturing the sclera and the choroid. A 33-gauge needle 
was then inserted into the globe via the sclerotomy in a tangential 
direction under an operating microscope. Fluorescein was added 
to the viral solution at a 1/1,000 final dilution, and the injection 
mixture was delivered into the subretinal space. The accuracy of 
the injections was monitored by fluorescence fundus photogra-
phy immediately following the injection procedure.
Eight animals received unilateral subretinal injection with 
either AAV2/5.CMV.d2GFP or sham injection with fluorescein. 
Two animals were injected subretinally with AAV2/5.CMV.
d2GFP in both eyes. Injected volume amounted to 1.5 µL per eye, 
and vector titer was 1 × 1011 vg/ml. Two untreated animals served 
as untreated controls. Animals were sacrificed 1 month and (in 
two cases) 12 months after treatment, respectively (Table 1).
AAV2/5.CMV.d2GFP was produced in the Vector Core at 
the University Hospital of Nantes (http://www.vectors.nantes.
inserm.fr), and the titer was determined by dot blot and expressed 
as vector genomes (vg) per milliliter. Viral preparation was manu-
factured using the HEK293 cell transfection method and puri-
fied by cesium chloride density gradients followed by extensive 
dialysis against phosphate-buffered saline (PBS).
Eyes were enucleated, anterior segments removed, and the 
eyecups immersion fixed in 4% paraformaldehyde (PFA) in 
0.1 M phosphate buffer (PB, pH 7.4) for 10–30 min, depending 
Table 1 | animals, age at treatment and examination, vector titer, injected volume, and fixation times.
animal eye Treatment injected 
volume 
(µl)
Titer Fixation 
(min)
age at 
treatment 
(months)
age at 
examination 
(months)
examinations performed
Fd lM eM TUnel Quant.
R1 OS – – – 10 – 12 X
OD – – – 30 X
R2 OS – – – 10 – 12 X
OD – – – 30 X
R3 OS AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 10 6 18 X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 30 X X
R4 OS AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 10 6 18 X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 20 X X
R5 OS – – – 15 6 7 X X X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 15 X X X X
R6 OS – – – 15 6 7 X X X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 15 X X X X
R7 OS – – – 15 6 7 X X X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml 15 X X X X
R8 OS – – – EM 6 7 X X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml EM X X X
R9 OS – – – EM 6 7 X X X
OD AAV2/5.CMV.d2GFP 1.5 3 × 1011 vg/ml EM X X X
R10 OS – – – 15 6 7 X X X X
OD Fluorescein 1.5 1:1,000 15 X X X X
R11 OS – – – 15 6 7 X X X X
OD Fluorescein 1.5 1:1,000 15 X X X X
R12 OS – – – 15 6 7 X X X X
OD Fluorescein 1.5 1:1,000 15 X X X X
OD, right eye; OS, left eye; Fd, funduscopy; LM, light microscopy and immunohistochemistry; vg/ml, vector genomes per milliliter; EM, electron microscopy; TUNEL, TUNEL assay; 
Quant., quantification of outer plexiform layer synapses.
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on the antibodies used (Table 2). After fixation, the retinas were 
dissected from the eyecup and cryoprotected in graded sucrose 
solutions (10, 20, and 30%, respectively).
immunohistochemistry and confocal 
Microscopy
Immunohistochemistry labeling was performed using the indi-
rect fluorescent method as previously described (33). Tissue was 
embedded in OCT medium (Jung, Nussloch, Germany), and 
vertical frozen sections of 16 µm were cut with a Leica cryostat.
Sections were washed in 0.1 M PB for 3 × 10 min and incu-
bated overnight with primary antibodies diluted in 3% normal 
donkey serum, 1% bovine serum albumin, and 0.5% Triton X-100 
in PBS (pH 7.4) at room temperature. Thereafter, sections were 
washed in PB and incubated with the secondary antibody for 
1  h. After a final washing step, cover slips were mounted with 
Aqua PolyMount (Polysciences, Warrington, PA, USA) and the 
sections were stored at 4°C for microscopy.
The primary antibodies used are listed in Table 2. As second-
ary antibodies both donkey anti-mouse and donkey anti-rabbit 
Alexa-Fluor 488 (green fluorescence; MoBiTech/Invitrogen, 
Karlsruhe, Germany) and Cy3 (red fluorescence; Dianova, 
Hamburg, Germany) were used, each diluted 1:500.
Confocal micrographs were taken using a confocal micro-
scope (AxioMOT with LSM 5 Pascal Module, Carl Zeiss, Jena, 
Germany) equipped with Argon and helium–neon lasers. Images 
were acquired sequentially for each channel with either a Plan 
Neofluar 40×/1.30 Oil objective or a Plan-Apochromat 63×/1.40 
Oil objective (Carl Zeiss, Jena, Germany) and using the LSM 
5 Pascal V3.2 SP2 software (Carl Zeiss, Jena, Germany). Final 
image adjustment for brightness and contrast was carried out 
with Photoshop CS5.1 (Adobe Systems, Munich, Germany).
electron Microscopy (eM)
Electron microscopy was carried out as previously described 
(34). Briefly, eyecups were immersion fixed with 2.5% gluta-
raldehyde and 4% PFA in PB. Subsequently, the retinae were 
dissected and washed in 0.1 M cacodylate buffer (pH 7.4) and 
thereafter incubated in 2% osmium tetroxide in cacodylate 
buffer and dehydrated in graded ethanol solutions (30, 50, 
70, 90, and 2  ×  100%). For contrasting, 2% uranyl acetate 
was added at the 70% ethanol dehydration step. After pre-
incubation with propylene oxide and epon (1:1) for 30 min, the 
sample was incubated overnight in pure epon, then embedded 
in silicone, and dried at 60° for 2 days. Serial ultrathin vertical 
sections were cut at 60–80  nm using a microtome, collected 
onto formvar-coated copper grids and then stained with uranyl 
acetate and lead citrate. Examination was performed with a 
LEO 912 AB Omega transmission electron microscope (Carl 
Zeiss, Jena, Germany).
Quantification of ribbon structures
In three animals that received unilateral injection with the 
green fluorescent protein (GFP) vector and three animals that 
received unilateral sham injection with fluorescein, the number 
of synaptic contacts between rod photoreceptors and rod bipolar 
Table 2 | Primary antibodies.
antibody host antibody 
type
Dilution specificity in the rat retina Manufacturer batch-no.
Apoptosis-inducing 
factor
rb Polyclonal 1:100 N/A Cell Signaling Technologies, 
Danvers, MA, USA
4642
Calcium-binding 
protein (calbindin)
ms Monoclonal 
IgG
1:1,000 Horizontal cells and some amacrine and ganglion 
cells
Swant, Bellinzona, Switzerland 300
Calbindin rb Polyclonal 1:2,000 Horizontal cells and some amacrine and ganglion 
cells
Swant, Bellinzona, Switzerland CB-38a
C-terminal-binding 
protein 2 (CtBP2)
rb Polyclonal 1:5,000 RIBEYE in synaptic ribbons of photoreceptor 
terminals and bipolar cells, CtBP2 in cell nuclei
Synaptic-Systems, Goettingen, 
Germany
193-003
Dihydropyridine (DHP) ms Monoclonal 
IgG
1:1,000–
1:2,000
Postsynaptic calcium channels in invaginating 
dendrites of rod bipolar cells and ON cone 
bipolar cells
Chemicon (Millipore), Billerica, 
MA, USA
MAB427
Glial fibrillary acidic 
protein
rb Polyclonal 1:1,000 Astrocytes, Müller cell endfeet at inner limiting 
membrane
Chemicon (Millipore), Billerica, 
MA, USA
AB5804
Green fluorescent 
protein
rb Polyclonal IgG 1:2,000 N/A Invitrogen, San Diego, CA, USA A-11122
Protein kinase C 
(PKCα)
rb Polyclonal 1:10,000 Rod bipolar cells and a subtype of amacrine cell Sigma-Aldrich, St. Louis, MO, 
USA
P4334
Postsynaptic density 
protein of 95 kDa
ms Monoclonal 
IgG
1:500 Presynaptic membrane of photoreceptor 
terminals in OPL, postsynaptic density at AMPA 
receptors in IPL
Affinity Bioreagents, Golden, 
CO, USA
MA1-046
ms, mouse; rb, rabbit; N/A, not applicable; IPL, inner plexiform layer; OPL, outer plexiform layer.
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cells was quantified, the contralateral untreated eyes serving as 
controls. For this purpose, three representative vertical sections 
from corresponding areas of each eye were examined. For better 
comparability, alignment of the samples, magnification, retinal 
thickness, and number of photoreceptor cell layers were kept 
constant throughout the examined sections. All sections were 
double labeled for C-terminal-binding protein 2 (CtBP2) and 
dihydropyridine (DHP). Acquired micrographs were split into 
the two respective color channels using ImageJ (Version 1.46i, W. 
S. Rasband, National Institutes of Health, Bethesda, CA, USA), 
and all clearly discernible synaptic ribbons in rod terminals and 
DHP-positive dendritic tips of rod bipolar cells were counted by 
the same examiner over the whole width of the microscopic scan 
(146 µm) using the Cell Counter PlugIn (Kurt de Vos, Academic 
Neurology, University of Sheffield, UK). Statistical analysis was 
performed with SPSS version 21 (IBM, Ehningen, Germany), 
using a one-way analysis of variance and the Kruskal–Wallis test 
for independent samples. A significance level of p ≤  0.05 was 
adopted.
apoptosis assay (TUnel)
A fluorometric DNA fragmentation detection kit (PromoCell, 
Heidelberg, Germany) was used to detect DNA ends, follow-
ing the manufacturer’s instructions. Digital micrographs were 
acquired using a BZ8000 fluorescence microscope (Keyence, 
Neu-Isenburg, Germany).
resUlTs
To visualize the transduced area, both in  vivo funduscopy and 
fluorescence microscopy were carried out. The AAV2/5 vector 
used in this study is known to transduce with high-efficiency pho-
toreceptors and RPE cells following subretinal injection. While 
we cannot assure 100% transduction efficacy inside the injected 
area, we do consider that almost all photoreceptor cells have been 
successfully targeted based on the images seen in Figure 1. In vivo 
funduscopy showed clearly visible GFP fluorescence restricted to 
the injection site. In retinal flat mounts, the GFP fluorescence 
was easily discernible using a fluorescence microscope with laser 
stimulation at 488  nm. In retinal vertical sections, transduced 
cells were labeled with GFP antibodies, showing a strong and 
homogenous signal in retinal photoreceptors (PR). The border of 
the transduced zone was clearly discernible, allowing comparison 
of retinal morphology within and outside the treated zone in the 
same eye (Figure 1).
Morphological structures are not altered 
1 and 12 Months after subretinal injection
Antibodies against calcium binding protein (CaBP), CtBP2, 
dihydropyridine (DHP), protein kinase C (PKCα), and post-
synaptic density protein (PSD95) were used to label structures of 
the OPL in vertical cryosections. With PSD95-immunolabeling 
PR synaptic terminals showed a homogenous distribution 
in two to five tightly packed rows (mostly representing rod 
spherules) immediately adjacent to the innermost cell layer of 
the outer nuclear layer (ONL) and above the OPL neuropil 
(Figures  2G,H). Similarly, with CtBP2 labeling, the synaptic 
ribbons showed a regular distribution within the OPL with no 
signals being dispersed into the adjacent ONL or inner nuclear 
layer (INL) (Figures  2A,B). In higher magnification micro-
graphs, the horseshoe-like structure of the ribbon within rod 
spherules was clearly discernible (Figures 2C,D). Arrangement 
FigUre 1 | localization of the adeno-associated virus-transduced 
area by green fluorescent protein (gFP) expression. (a) In vivo 
funduscopic image of a transduced rat retina 4 weeks after subretinal 
injection into the mid-peripheral retina. The strong, punctate fluorescence 
signal corresponds to the GFP expression in RPE cells. The weaker, 
homogenous fluorescence corresponds to the GFP expression in transduced 
PR cells. (b) Sketch of a flat-mounted retina. The area of GFP expression is 
marked green. The red lines indicate the portion prepared for vertical 
cryosections. (c) Vertical section through the area highlighted in panel 
(b) showing the transition zone between the GFP-transduced area and the 
non-transduced area lying toward the central portion of the retina. n = 7 
transduced eyes. IS, inner segments of PR; ONL, outer nuclear layer; OPL, 
outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, 
ganglion cell layer. Scale bar in panel (c): 20 µm.
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of rod spherules or photoreceptor terminals in general did not 
show anomalies in transduced retinas. The horseshoe structure of 
the synaptic ribbon was preserved and did not show shortening, 
fractioning, or clumping as has been described for animal models 
of retinal detachment or retinal degeneration. Particularly, no 
ectopic synapses were apparent in treated, sham-injected, and 
control animals, respectively.
PKCα immunolabeling showed a normal staining pattern for 
rod bipolar cells, their dendritic branches, contacting approxi-
mately 15–50 rod spherules each, being clearly distinguishable 
as fine strands stretching vertically through the OPL until 
just underneath the ONL (Figures  2E,F). As an indicator for 
functioning signal transmission from rods to rod bipolar cells 
DHP antibodies were used, highlighting clusters of voltage-
gated calcium channels at the invaginating tips of bipolar cells 
(Figures  2E,F). With usually two tips of distinct bipolar cells 
present in each rod spherule synaptic invagination, giving it 
the typical triad arrangement, this results in a fluorescence 
pattern of two roughly circular and closely adjoined dots. Both, 
in treated retinas and controls, the DHP signal was directly 
mounted on the tips of rod bipolar dendritic processes and 
in close apposition to the synaptic ribbon in rod spherules. 
No loss or pruning of terminal dendritic branches in treated 
or sham-injected retinas was observed. Neuritic outgrowth or 
downregulation of postsynaptic receptor molecules could not 
be detected.
Green fluorescent protein expression within the PR remained 
stable even 12 months after treatment (data not shown). No altera-
tion of OPL synaptic structures was observed with the markers 
used. Particularly, no PR terminal withdrawal or second-order 
neurite outgrowth were present in treated retinas. Overall retinal 
thickness appeared reduced in the older animals. However, this 
effect was likely due to age-associated degeneration or in any case 
light-induced damage, as it was equally observed in untreated 
controls.
no Ultrastructural Modifications of the 
Photoreceptor ribbon synapses
Compared to untreated controls, the overall shape of rod ter-
minals and their compact arrangement above the OPL neuropil 
within transduced areas appeared unchanged (Figures  3A,B). 
The cytoplasm was packed with synaptic vesicles, and the synapse 
with the second-order cells showed the typical triad structure 
with one clearly discernible ribbon and the associated invaginat-
ing processes of two horizontal cell axons as lateral elements and 
one to two bipolar cell dendrites in the center. The invaginations 
had a depth of approximately 1 µm, and the narrow hilus through 
which second-order neurites have to pass was clearly visible. 
Structural alterations as described after retinal detachment, such 
as fractioning or shortening of the synaptic ribbon, flat or missing 
invaginations of the basal cell membrane, or thickening of second 
order neurites along with disaggregation of the OPL neuropil, 
were not observed.
Similarly, cone pedicles in transduced areas had an unaltered 
overall aspect concerning shape and arrangement (Figures 3C,D). 
They showed an orthogonal diameter of approximately 5–7 µm, 
and their flat base was disrupted by multiple deep invaginations. 
Immediately adjoining the base of the cone pedicle lays the OPL 
neuropil with tightly packed processes of horizontal and bipolar 
cells. The fine postsynaptic processes, especially those of the 
horizontal cells, did not show any signs of swelling or hypertro-
phy compared to untreated controls. Within the cone pedicle, a 
number of intact ribbons were present, which were organized to 
typical triads with their postsynaptic partners. Basal cell contacts 
also did not show obvious discrepancies compared to healthy 
controls.
absolute numbers of ribbons are similar 
in Transduced and non-Transduced areas
To examine the question of whether the transgene expression 
or the subretinal injection lead to a decrease in the number of 
synaptic interconnections within the OPL, the eyes of six uni-
laterally injected animals were studied 1 month after treatment 
(Figure 4). In this experimental setup, no statistically significant 
differences in the number of CtBP2- and DHP-positive signals 
were observed in the OPL of GFP-transduced, fluorescein-
injected, and untreated eyes, respectively. In GFP-transduced 
retinas 97 (SD ±  11.1) CtBP2-positive synaptic ribbons were 
counted as opposed to 95.3 (±16.5) in the sham-injected 
retinas and 96.3 (±12.5) in the untreated controls (p =  0.966 
and p =  0.816 for ANOVA and Kruskal–Wallis, respectively). 
FigUre 2 | Vertical cryosections of the retinas of adeno-associated virus (aaV)-transduced (left column) and untreated control animals (right 
column) with antibodies against different outer plexiform layer (OPl) structures. (a) AAV-transduced area in treated animal. The GFP fluorescence in 
the photoreceptors is clearly discernible. (b) Untreated control. (c,D) Higher magnification images of the areas highlighted in panels (a,b) with antibodies 
against C-terminal-binding protein 2 (CtBP2) (red) staining photoreceptor synaptic ribbons and calcium-binding protein (CaBP) (green) marking horizontal cells. 
(e,F) OPL of treated (left) and untreated (right) retinas with antibodies for DHP (red) marking voltage-gated calcium channels on invaginating bipolar cell 
dendritic tips and PKCα (green) marking rod bipolar cells. (g,h) OPL of treated (left) and control (right) retinas with antibodies for PSD95 (red) and CaBP 
(green). Structure and arrangement as well as overall number of synaptic contacts between first and second order neurons do not appear to be altered in 
treated retinas. n = 5 AAV-transduced eyes and n = 5 untreated controls. Abbreviations: compare Figure 1. Scale bar in panel (b) [for panels (a,b)]: 20 µm; 
scale bar in panel (F) [for panels (c–h)]: 10 µm.
6
Giers et al. AAV in Healthy Rat Retina
Frontiers in Neurology | www.frontiersin.org February 2017 | Volume 8 | Article 59
Accordingly, 92.4 (±9.5) DHP-positive postsynaptic clusters 
were counted in GFP-transduced retinas as opposed to 95.8 
(±12.1) in the sham-injected and 95.7 (±15.6) in the untreated 
control retinas (p  =  0.810 and p  =  0.645 for ANOVA and 
Kruskal–Wallis, respectively).
Müller cell reaction
On immunostaining for glial fibrillary acidic protein (GFAP), 
untreated eyes displayed a fluorescence pattern limited to the 
nerve fiber or ganglion cell layer (GCL) (Figures 5C,E,F). This 
corresponds to the distributional pattern of retinal astrocytes, 
which are regularly GFAP-positive and are involved both in the 
formation of the blood–retinal barrier and the inner limiting 
membrane (ILM), as well as that of Müller cell endfeet, in which 
GFAP is also weakly expressed. In GFP-transduced animals, 
a distinct fluorescence pattern of radially arranged fibers was 
observed within the area of GFP expression (Figures  5A,B), 
which extended throughout the entire retina from the inner to 
the outer limiting membrane and corresponds to the typical fluo-
rescence pattern of Müller cells. Similarly, eyes that only received 
a sham injection with fluorescein displayed fibrillary “sprouts,” 
reaching from the ILM far into the INL (Figure 5D), which was 
well consistent with the fluorescence pattern seen in Müller cells 
after traumatic manipulation.
An increase of Müller cell processes in the regions of the 
inner or outer limiting membrane and particularly outgrowths 
of GFAP-positive fibrils into the subretinal or vitreal space were 
not observed.
no sign of increased apoptosis in the 
Transduced area
Two methods were used to assess the apoptotic status of examined 
retinas: immunostaining for apoptosis-inducing factor (AIF) and 
a TUNEL assay to detect DNA double-strand breaks.
Apoptosis-inducing factor is a flavoprotein expressed by 
eukaryotic cells that plays a key role in initiating programmed 
FigUre 3 | electron micrographs from the outer plexiform layer of adeno-associated virus (aaV)-transduced [left column: panels (a,c)] and 
untreated control [right column: panels (b,D)] retinas. (a,b) Rod spherules (red) displaying a synaptic ribbon (arrowheads) opposing the invaginating dendrites 
of horizontal and bipolar cells. In conjunction, these three elements form what is called a synaptic triad. (c,D) Cone pedicles (blue) with invaginating and basal 
synaptic cell contacts. n = 2 AAV-transduced eyes and n = 2 untreated controls. Arrowheads: ribbon synapses. Scale bar in panels (a–D): 1 µm.
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cell death. It is usually located within the inter-membranous 
gaps of mitochondria. In apoptotic cells, a dislocation of AIF 
into the cytosol and the nucleus is observed. Immunolabeling of 
treated and sham-injected rat retinas with AIF antibodies leads 
to a strong fluorescence signal within the PR inner segments, 
where most of the cells mitochondria are located. A dislocation 
of the fluorescence signal into the cell body was not observed 
(Figures 6E,F).
In the TUNEL assay, DNA double-strand breaks are made 
visible by specific binding of free 3′-OH ends of DNA fragments. 
In our experimental setup, neither GFP-transduced nor sham-
injected retinas showed an increased number of apoptotic nuclei 
as compared to retinal regions from outside the injection bleb or 
healthy controls (Figures 6A–D).
DiscUssiOn
In this study, we show that subretinal delivery of AAV vectors 
does not cause significant alterations to structures in the OPL in 
terms of qualitative features, such as increased sprouting of bipolar 
cells or synaptic ribbon structures, or quantitative features, such 
as the absolute number of synaptic terminals. This intervention 
also does not cause increased rates of photoreceptor apoptosis.
When looking at AAV gene transfer into the retina by 
subretinal delivery route, several issues have to be taken into 
account when analyzing the effects of such an intervention on the 
morphology of the photoreceptor cells. Subretinal delivery causes 
a transient retinal detachment, the intracellular presence of the 
viral vector potentially induces cellular stress, and the transgene 
FigUre 5 | Vertical sections of rat retinas with labeling for glial fibrillary acidic protein (gFaP) (Müller cells). (a) Green fluorescent protein (GFP)-
transduced area. The GFP fluorescence within photoreceptors is clearly discernible. (b) Red channel from panel (a). Arrow heads mark the outer limiting membrane; 
arrows point out the inner limiting membrane. (D) Section through a retina sham injected with fluorescein. (c,e) Healthy controls, peripheral retina. (F) Healthy 
control, central retina. The GFAP signal is clearly elevated in treated and sham-injected areas, extending far into the inner nuclear layer (INL) and sometimes staining 
the entire Müller cell body. n = 3 for adeno-associated virus-transduced and fluorescein-injected eyes, and n = 6 for untreated control eyes. Abbreviations: compare 
Figure 1. Scale bar in all panels: 20 µm.
FigUre 4 | Quantification of synapses in the outer plexiform layer (OPl). Boxplots showing the mean number (±1 SD) of counted signals in the OPL for 
synaptic ribbons [C-terminal-binding protein 2 (CtBP2)] and bipolar cell dendritic tips (DHP) in adeno-associated virus (AAV)-transduced areas (transduced), areas 
sham-injected with fluorescein (sham), and untreated controls (control). n = 3 for AAV-transduced and fluorescein-injected eyes, and n = 6 for untreated control 
eyes.
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FigUre 6 | assessment of apoptosis in treated versus untreated retinas. (a–D) TUNEL assay. (a) Positive control. (b) Negative control. (c) Adeno-
associated virus (AAV)-transduced retina. (D) Retina from untreated eye. (e,F) Vertical cryosections with staining for apoptosis-inducing factor (AIF). (e) AAV-
transduced retina. The green fluorescent protein fluorescence in the photoreceptors is easily discernible. (F) Untreated control retina. The AIF signal is evenly 
distributed in the inner segments of photoreceptor, showing no sign of dislocation into the cell bodies. n = 3 for AAV-transduced and fluorescein-injected eyes, and 
n = 6 for untreated control eyes. Abbreviations: compare Figure 1. Scale bar in panel (D) [for panels (a–D)]: 50 µm. Scale bar in panel (F) [for panels (e,F)]: 20 µm.
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can prevent the transduced cells from functioning normally. 
While the latter point is directly related to the amount of GFP 
produced in photoreceptor cells, it was shown that even high 
intracellular concentrations of GFP did not have toxic effects (35, 
36). Likewise, even though it has been shown that AAV vector 
particles can persist in photoreceptors following subretinal injec-
tion for a long time (37), any toxicity related to the viral vector 
itself has not been reported so far.
By contrast, it is known that AAV-mediated gene delivery 
by subretinal injection leads to a transient retinal detachment, 
which in most cases resolves spontaneously within 24–48  h, 
by which time photoreceptors and retinal pigment epithelial 
cells have been transduced by the viral vector. The retinal 
detachment itself can lead to a number of distinct changes 
in retinal morphology, ultrastructure, and protein expression 
of retinal cells. The changes that detached retinas undergo 
follow a reproducible pattern and have been described in great 
detail (29). Part of these processes are reversible and seem 
to have in fact a protective function by downregulating cell 
metabolism and thereby enabling cell survival in detached 
retinal regions (38).
The volume that is introduced into the subretinal space 
determines in large part the area being detached, which means 
that larger volumes generally detach a larger retinal zone. 
This is associated with shear stress to the retina, representing 
a potentially negative factor concerning the morphological 
integrity. In our study, we injected 1.5 µL vector solution, thereby 
resulting in the detachment of about 20% of the retinal zone. 
No apparent morphological changes with regard to this stress 
factor were observed. Since we did not detach a larger area, the 
physical stress to the detached healthy retina was probably at a 
lower level as compared to the stress induced when larger parts of 
the retina would be detached. However, in clinical trials, retinal 
detachments are also limited to defined areas and do not include 
more than 30% of the retina being detached at once, making our 
setup relevant in this regard (14–17). However, one limitation 
remains the fact that we were studying the effects in a healthy 
retina, while the consequences of physical stress during the 
detachment might be more important in retinal tissue undergo-
ing neuroretinal degeneration. This question is now subject to 
ongoing investigations.
Synaptic sprouting has also been observed in animal models 
of experimental retinal detachment. However, the level of 
sprouting appears to depend on the duration of the detachment 
and is also in part reversible (29, 30, 38). Even in retinas that 
had been detached for several days, a “restructuring” of the 
OPL was observed with most ectopic synapses disappearing 
and ONL thickness increasing within a couple of weeks after 
reattachment (29, 38).
In our study, we did not observe increased rates of sprouting 
when looking at the OPL of retinas 1 or 12  months following 
subretinal AAV gene delivery. It is very likely that any potential 
transient changes that might have occurred shortly after the 
delivery were reversed and did not have a pronounced effect 
on the structure of the photoreceptor terminals. Likewise, the 
absolute number of ribbon synapses was not altered in retinas 
transduced by AAV vectors or retinas injected with fluorescein 
alone, indicating that the AAV delivery itself is not harmful to 
the retinal structure. The presence of AAV particles in confined 
compartments within the photoreceptor terminals, which was 
shown in a previous study (37), and which might also be the case 
in the terminals of transduced photoreceptors analyzed in this 
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study (although not detectable on EM images), also does not 
seem to have an effect on the synaptic architecture.
Müller cells seem to react very rapidly to an experimental 
retinal detachment by changing their expression profile, usu-
ally leading to a pronounced upregulation of GFAP expression. 
Similarly, we also observed an increased expression of GFAP 
in the transduced retinae, seen as fibers in parallel formation 
stretching from the ILM and the GCL into the outer retinal layers, 
and in some cases all the way to the outer limiting membrane, 
corresponding to the typical shape and arrangement of Müller 
cells (39), and indicating a similar response of the Müller cells 
to subretinal delivery of AAV. Since the same reaction was found 
both, in animals that received subretinal gene transfer and in 
animals that were sham injected with fluorescein, we conclude 
that the upregulation of GFAP in Müller cells seen in our study 
is a consequence of the transient retinal detachment itself and 
not related to the gene delivery or the presence of viral particles 
in the retina.
Increased rates of apoptosis of photoreceptor cells were found 
in experimental retinal detachment studies (40). Apoptotic 
activity was strongest between 24 and 72 h after detachment, at 
which time approximately 20% of photoreceptors were lost (38, 
40). However, even in long-term detachment (up to 450 days in 
the animal model), about half of the photoreceptor population 
was preserved (41). In our study, we did not find an increase 
of apoptotic nuclei in GFP-transduced areas as compared to 
sham-injected retinas and healthy controls. Furthermore, 
AIF was not delocalized from the PR IS into the cytosol and 
the nucleus. Taking into account the normal overall appear-
ance of the retinal tissue by light microscopy and comparable 
retinal layer thickness, we conclude that there is no increase 
of apoptotic cell death in GFP-transduced and sham-injected 
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